GlassScriptPhysician profile
William Keith Harris
NPI 1902874571
$5,178.96
in general payments reported to CMS, 2019-2025
36 companies · $1,252 in 2025
The $1,252 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $484 · 2020: $420 · 2021: $486 · 2022: $734 · 2023: $949 · 2024: $854 · 2025: $1,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,055.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $967.69 | 2019-2025 | |
| Abbvie INC. | $903.16 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $362.20 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $347.72 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $337.76 | 2020-2025 | Jardiance |
| Glaxosmithkline, LLC. | $269.53 | 2022-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Amgen INC. | $255.54 | 2019-2025 | Repatha, Otezla, Otezla |
| Merck Sharp & Dohme LLC | $242.08 | 2019-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Exact Sciences Corporation | $159.99 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $152.61 | 2023-2025 | Freestyle Libre |
| Novartis Pharmaceuticals Corporation | $146.57 | 2022-2025 | |
| Amarin Pharma, INC. | $120.89 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $75.45 | 2022 | |
| Novo Nordisk INC | $71.35 | 2020-2025 | Ozempic |
| Phathom Pharmaceuticals, INC. | $67.57 | 2024-2025 | Voquezna |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.